Ionic regulation of the binding of DL-[3H]2-amino-4-phosphonobutyrate to L-glutamate-sensitive sites on rat brain membranes

Removal of extracellular chloride suppresses transmitter release from photoreceptor terminals in the mudpuppy retina

Removal of extracellular Cl- has been shown to suppress light-evoked voltage responses of ON bipolar and horizontal cells, but not photoreceptors or OFF bipolar cells, in the amphibian retina. A substantial amount of experimental evidence has demonstrated that the photoreceptor transmitter, L-glutamate, activates cation, not Cl-, channels in these cells. The mechanism for Cl-free effects was therefore reexamined in a superfused retinal slice preparation from the mudpuppy (Necturus maculosus) using whole-cell voltage and current clamp techniques. In a Cl-free medium, light-evoked currents were maintained in rod and cone photoreceptors but suppressed in horizontal, ON bipolar, and OFF bipolar cells. Changes in input resistance and dark current in bipolar and horizontal cells were consistent with the hypothesis that removal of Cl- suppresses tonic glutamate release from photoreceptors. The persistence of light-evoked voltage responses in OFF bipolar cells, despite the suppression of light-evoked currents, is due to a compensatory increase in input resistance. Focal application of hyperosmotic sucrose to photoreceptor terminals produced currents in bipolar and horizontal cells arising from two sources: (a) evoked glutamate release and (b) direct actions of the hyperosmotic solution on postsynaptic neurons. The inward currents resulting from osmotically evoked release of glutamate in OFF bipolar and horizontal cells were suppressed in a Cl-free medium. For ON bipolar cells, both the direct and evoked components of the hyperosmotic response resulted in outward currents and were thus difficult to separate. However, in some cells, removal of extracellular Cl- suppressed the outward current consistent with a suppression of presynaptic glutamate release. The results of this study suggest that removal of extracellular Cl- suppresses glutamate release from photoreceptor terminals. Thus, it is possible that control of [Cl-] in and around photoreceptors may regulate glutamate release from these cells.

Alterations of G-protein coupling function in phosphoinositide signalling pathways of rat hippocampus by ischaemic brain injury

The activation of membrane-associated phospholipase C is rapidly and transiently induced in the central nervous system by a variety of stimuli. Ischaemic brain injury is one of the situations that leads to a dramatic increase in polyphosphoinositide (PPI) turnover. In this study, stimulation of PPI hydrolysis by glutamate (500 microM) was measured in hippocampal slices from rats up to 21 days after an ischaemic insult of 30 min. Ischaemia was induced using the four-vessel occlusion method. PPI hydrolysis elicited by glutamate was significantly increased in the slices prepared from ischaemic rats 24 h after reperfusion, the accumulation of inositol phosphates (InsPs) and inositol 1,4,5-trisphosphate (Insp3) was 614 +/- 74% (n = 8) and 182 +/- 11% (n = 9) of the basal level respectively. This potentiation was also observed 21 days after ischaemia. Hyper-responsiveness to glutamate was also accompanied by an increase in AIF4(-)-stimulated formation of [3H]inositol phosphates. In addition, global ischaemia did not change either high-affinity [3H]glutamate binding in hippocampal membranes or the stimulation of PPI hydrolysis by carbachol or noradrenaline in hippocampal slices. The present results suggest that the increased responsiveness to glutamate is the result, at least in part, of functional changes at the G-protein level, and may contribute to the pathophysiology of ischaemic brain injury or to the regenerative phenomena that accompany ischaemic damage.

Inhibitory modulation by sodium ions of the N-methyl-D-aspartate recognition site in brain synaptic membranes

Specific binding of radiolabeled L-glutamic acid (Glu) was examined using rat brain synaptic membranes treated with a low concentration of Triton X-100. The binding drastically increased in proportion to increasing concentrations of the detergent used up to 0.1%. Addition of 100 mM sodium acetate significantly potentiated the binding in membranes not treated with Triton X-100, whereas it markedly inhibited the binding in Triton-treated membranes. The binding in Triton-treated membranes was inversely dependent on incubation temperature and reached a plateau within 10 min after the initiation of incubation at 2 degrees C, whereas the time required to attain equilibrium at 30 degrees C was less than 1 min. Sodium acetate invariably inhibited the binding detected at both temperatures independently of the incubation time via decreasing the affinity for the ligand. The binding was significantly displaced by agonists and antagonists for an N-methyl-D-aspartate (NMDA)-sensitive subclass of brain excitatory amino acid receptors, but not by those for the other subclasses. Inclusion of sodium acetate reduced the potencies of NMDA agonists to displace the binding without virtually affecting those of NMDA antagonists. Moreover, sodium ions inhibited the ability of Glu to potentiate the binding of N-[3H] [1-(2-thienyl)cyclohexyl]piperidine to open NMDA channels in Triton-treated membranes. These results suggest that sodium ions may play an additional modulatory role in the termination process of neurotransmission mediated by excitatory amino acids via facilitating a transformation of the NMDA recognition site from a state with high affinity for agonists to a state with low affinity.

Neurochemical aspects of the N-methyl-D-aspartate receptor complex

The N-methyl-D-aspartic acid (NMDA)-sensitive subclass of brain excitatory amino acid receptors is supposed to be a receptor-ionophore complex consisting of at least 3 different major domains including an NMDA recognition site, glycine (Gly) recognition site and ion channel site. Biochemical labeling of the NMDA domain using [3H]L-glutamic acid (Glu) as a radioactive ligand often meets with several critical methodological pitfalls and artifacts that cause a serious misinterpretation of the results. Treatment of brain synaptic membranes with a low concentration of Triton X-100 induces a marked disclosure of [3H]Glu binding sensitive to displacement by NMDA with a concomitant removal of other several membranous constituents with relatively high affinity for the neuroactive amino acid. The NMDA site is also radiolabeled by the competitive antagonist (+/-)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid that reveals possible heterogeneity of the site. The Gly domain is sensitive to D-serine and D-alanine but insensitive to strychnine, and this domain seems to be absolutely required for an opening of the NMDA channels by agonists. The ionophore domain is radiolabeled by a non-competitive type of NMDA antagonist that is only able to bind to the open but not closed channels. The binding of these allosteric antagonists is markedly potentiated by NMDA agonists in a manner sensitive to antagonism by isosteric antagonists in brain synaptic membranes and additionally enhanced by further inclusion of Gly agonists through the Gly domain. Furthermore, physiological and biochemical responses mediated by the NMDA receptor complex are invariably potentiated by several endogenous polyamines, suggesting a novel polyamine site within the complex. At any rate, activation of the NMDA receptor complex results in a marked influx of Ca2+ as well as Na+ ions, which subsequently induces numerous intracellular metabolic alterations that could be associated with neuronal plasticity or excitotoxicity. Therefore, any isosteric and allosteric antagonists would be of great benefit for the therapy and treatment of neurodegenerative disorders with a risk of impairing the acquisition and formation process of memories.

Evidence for excitatory amino acid transmission between mesencephalic nucleus of V afferents and jaw-closer motoneurons in the guinea pig

Previous studies have suggested that monosynaptic transmission between spinal primary afferent fibers and motoneurons is mediated by an excitatory amino acid, most likely glutamate or aspartate. No such comparable studies have been carried out in the trigeminal system. In an attempt to elucidate the neurotransmitter(s) mediating monosynaptic transmission between mesencephalic of V nucleus afferents (Mes V) and trigeminal jaw-closer motoneurons, the effect of iontophoretic application of excitatory amino acid antagonists on the Mes V-induced field potential, recorded in the trigeminal motor nucleus (Mot V), was examined. Application of DL-2-amino-4-phosphonobutyrate (APB) and the broad spectrum amino acid antagonists, kynurenic acid (KYN) and gamma-D-glutamylglycine (DGG), for 3-4 min reversibly reduced the amplitude of the Mes V induced field potential. The effect of APB was much greater than any of the other compounds tested. On the other hand, the specific N-methyl-D-aspartate (NMDA) receptor blocker DL-2-amino-5-phosphonovaleric acid (APV), was without effect on the field potential. Based on current-response curves for each antagonist tested, the order of potency was determined to be APB greater than KYN greater than DGG greater than APV. These antagonists were also compared with respect to their efficacy in blocking individual jaw-closer motoneuron activity induced by iontophoretic application of amino acid receptor excitants glutamate (Glut), aspartate (Asp), kainate (K), and quisqualate (Q). NMDA application was without effects on these motoneurons. The profile of activity of these antagonists on these amino acid excitants was similar to that found in other areas of the CNS by other investigators. KYN and DGG both significantly reduced responses induced by all excitants tested, whereas APB had more modest effects on K and Q excitation and was without effect on Glut and Asp excitations in most cells tested. The data suggest that an excitatory amino acid, activating non-NMDA receptors, mediates some component of synaptic transmission between Mes V afferents and jaw-closer motoneurons. The data is also consistent with the proposal made in other systems that APB blocks synaptic transmission by a mechanism other than postsynaptic receptor blockade.

AP4 inhibits chloride-dependent binding and uptake of [3H]glutamate in rabbit retina

Glutamate is one of the major neurotransmitters used by primary and secondary neurons of the visual pathway in retina. AP4(2-amino-4-phosphonobutyric acid) preferentially blocks the activity of one functional subclass of retinal neurons, ON bipolar cells, apparently by acting as an agonist at a hyperpolarizing glutamate receptor. We have used in vitro binding assays to examine different subclasses of presumptive glutamate receptors in retinal membrane fractions. One subclass consists of AP4-sensitive binding sites which require calcium and chloride for maximal binding and which are inhibited by freeze-thaw procedures. In addition, AP4 inhibits chloride-dependent [3H]glutamate uptake into retinal synaptosomes and intact retina. [3H]glutamate which is accumulated via the AP4-sensitive mechanism can be subsequently released by depolarizing levels of potassium. The pharmacological selectivity of AP4-sensitive glutamate receptors on ON bipolar cells measured electrophysiologically is very similar to that of AP4-sensitive, [3H]glutamate binding and uptake, measured biochemically in subcellular fractions. These results raise the possibility that AP4-sensitive glutamate recognition sites in retina may be linked to two separate effectors, one which gates ion channels and leads to hyperpolarization, and another which acts as a glutamate transporter.

Neurotransmitter systems in the outer plexiform layer of mammalian retina

Melatonin represents a second type of chemical signal released from photoreceptors in response to increased darkness, one with characteristics which are significantly different from those of glutamate. Concise spatial and temporal aspects of the photoreceptor signal are conserved through discrete glutamatergic synapses. Different classes of post-synaptic neurons each have appropriate subclasses of glutamate receptors which transmit sign conserving or sign inverting images of the visual mosaic. In contrast, melatonin, because of its highly lipophilic nature is not released by stimulus-coupled secretion mechanisms, but rather by simple diffusion. Thus control of melatonin "release" may be less concise than glutamate. In addition, melatonin may diffuse beyond the confines of the synaptic area to target cells throughout the retina. Effects of melatonin in retina are not well understood; however, current hypotheses suggest that, perhaps via its control of dopamine systems in the inner retina, melatonin plays an important role in dark adaptation and in various retinal processes which exhibit a circadian rhythm. Melatonin and glutamate may represent "co-transmitters" which provide the visual pathway with two types of signals, with melatonin providing widespread modulatory influences on the discrete visual information conveyed via glutamatergic circuits.

DL-2-[3,4-3H]amino-4-phosphonobutyrate binding sites in the rat hippocampus: distribution and possible physiological role

Binding sites for the novel, glutamate-like radioligand DL-2-[3,4-3H]amino-4-phosphonobutyrate (DL-[3H]APB) on rat hippocampal synaptic membranes were identified and characterised. The existence of a single, saturable population of binding sites was demonstrated. These appeared to be indistinguishable, in terms of their pharmacological profile and ionic dependence, from those described previously in the striatum and whole brain. The distribution of these sites was also examined using a number of discrete neuronal lesions. A majority of sites (approx. 55%) were located on dentate gyrus granule cells. Smaller populations appeared to be situated on perforant path terminals and on pyramidal cells. However, L-APB was found to be ineffective as an inhibitor of basal and potassium evoked D-[3H]aspartate release from hippocampal slices. A presynaptic location can therefore presumably be ruled out. The likely postsynaptic location of DL-[3H]APB-binding sites in the hippocampus suggests that this site may be involved in synaptic neurotransmission. This possibility is discussed with regard to electrophysiological data concerning the synaptic pharmacology of neuronal connections within the hippocampus.

A novel chloride-dependent L-[3H]glutamate binding site in astrocyte membranes

Membrane fractions prepared from astrocytes grown in culture exhibit a specific binding site for L-[3H]glutamate that is Cl--dependent and Na+-independent. The binding site is a single saturable site with a KD of about 0.5 microM, is inhibited by L-aspartate, L-cysteate, and quisqualate, and is insensitive to kainate, N-methyl-D-aspartate, alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate, and 2-amino-4-phosphonobutyrate. The pharmacological characteristics of the binding site indicate that it is distinct from any site previously described in synaptic membrane preparations. Comparisons of ionic requirements, ligand specificity, and inhibitor sensitivities, however, suggest the described binding is the first step in a Cl--dependent high-affinity glutamate uptake system. Such binding studies provide a useful model system in which to investigate the close association between excitatory amino acids, astrocytes, the termination of glutamate's excitatory action by high-affinity uptake, and the excitotoxic action of acidic amino acids in membranes of a single cell type.

Are Ca2+-dependent proteases really responsible for Cl(-)-dependent and Ca2+-stimulated binding of [3H]glutamate in rat brain?

The role of Ca2+ ions in [3H]glutamate binding was re-examined using synaptic membranous preparations obtained from the rat brain. In vitro addition (0.1-5 mM) of calcium chloride exhibited a profound enhancement of the binding in a temperature-dependent manner, whereas that of calcium acetate had no significant effect on the binding independently of the incubation temperature. Calcium acetate elicited a significantly additional stimulation of the Cl(-)-induced and temperature-dependent facilitation of the binding. The augmentation by these two ions was invariably eliminated by the addition of an antagonist for the anion channels including picrotoxinin as well as of inhibitors of anion transport such as ethacrynic acid and 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid. L-Aspartate exerted a more potent inhibitory action on the Cl(-)-dependent binding and Cl(-)-dependent and Ca2+-stimulated binding, than D-aspartate. The latter two bindings were selectively abolished by an agonist (quisqualic acid) and an antagonist (DL-2-amino-4-phosphonobutyric acid) for central glutamate receptors, respectively. It was also found that pretreatment of the membranes with calcium acetate resulted in a complete abolishment of the Ca2+-stimulated binding with a concomitant stimulation of the Cl(-)-dependent binding, which invariably occurred independently of the preincubation temperature (2 or 30 degrees C). No significant alteration was detected in the basal binding following the latter pretreatment. None of various protease inhibitors such as leupeptin, antipain, chymostatin and pepstatin induced a significant alteration in the basal, Cl(-)-dependent, Ca2+-stimulated and Na+-dependent bindings of [3H]glutamate, respectively. These results suggest that Ca2+ ions may elicit their stimulatory action on the Cl(-)-dependent binding of [3H]glutamate even in the absence of Cl- ions added through the temperature-independent and apparently irreversible interaction with the anion transport carriers rather than the direct action on the binding sites of the ligand. The evidence presented here also suggests that the widely held view that Ca2+-dependent proteases are responsible for the exhibition of Cl(-)-dependent and Ca2+-stimulated binding of [3H]glutamate may need to be re-evaluated.

Characterization of Na+-dependent binding sites of [3H]glutamate in synaptic membranes from rat brain

Some biochemical characteristics of Na+-dependent binding of [3H]L-glutamic acid (Glu) were studied using crude synaptic membrane preparations from the rat brain as compared with Na+-independent binding. In vitro addition of sodium chloride (1-100 mM) exhibited a significant enhancement of [3H]Glu binding to synaptic membranes in a concentration-dependent manner independent of the incubation temperature employed (2 or 30 degrees C). In contrast, sodium acetate elicited a concentration-dependent augmentation of the binding at 2 degrees C to a significantly greater extent than that found at 30 degrees C. It was found that the binding found in the presence of 100 mM sodium acetate reached its maximal value within 10 min of incubation followed by a rapid decline up to 60 min at 30 degrees C, while gradually increasing up to 60 min at 2 degrees C. The Na+-independent basal binding was significantly activated by the alteration of incubation temperature from 2 to 30 degrees C and reached equilibrium within 10 min of incubation at both incubation temperatures. The Na+-dependent binding was more promptly attenuated by the addition of excess of non-radioactive Glu (1 mM) at 30 degrees C than that at 2 degrees C, whereas the Na+-independent binding was greatly suppressed by the addition at 2 degrees C in comparison with that at 30 degrees C. Quisqualic acid induced a considerably less-potent inhibition of the Na+-dependent binding than that of the Na+-independent binding. Neither N-methyl-D-aspartic acid nor kainic acid had such a significant effect on each binding.(ABSTRACT TRUNCATED AT 250 WORDS)

The distribution and function of DL-[3H]2-amino-4-phosphonobutyrate binding sites in the rat striatum

The binding of the glutamate-like radioligand, DL-[3H]2-amino-4-phosphonobutyrate (DL-[3H]APB), to L-glutamate-sensitive sites in the rat striatum was investigated. A single, saturable population of binding sites, indistinguishable from that characterized previously on rat whole brain synaptic membranes, was identified. The effects of specific lesions of the striatum: decortication; striatal injection of kainic acid; and 6-hydroxydopamine injections into the substantia nigra, were also examined. Specific DL-[3H]APB binding in the striatum was elevated significantly following decortication. An increase in the number of binding sites was found to be responsible for this enhancement in binding. Lesions of the postsynaptic targets of corticostriatal fibres reduced the number of DL-[3H]APB binding sites in the striatum without affecting binding site affinity. This finding suggests that L-APB sensitive excitatory amino acid receptors are located predominantly on membranes derived from structures postsynaptic with regard to the glutamatergic innervation. The possible physiological role of these receptors was examined using an in vitro release technique. Both L-glutamate and L-APB were found to facilitate potassium evoked [3H]dopamine release from striatal slices. This finding supports the proposed existence of functional acidic amino acid receptors on dopaminergic terminals in the striatum. These receptors may play an important role in the control of motor function.

Ionic regulation of the binding of DL-2-amino-7-phosphono-[4,5-3H]heptanoic acid to synaptosome-enriched homogenates of rat cerebral cortex

The ionic requirements of the site labelled by DL-2-amino-7-phosphono-[4,5-3H]heptanoic acid ([3H]DL-2AP7) in synaptosome-enriched homogenates of rat cerebral cortex were examined using radioligand binding methodology. Binding of [3H]DL-2AP7 was increased by calcium and chloride ions by an apparently non-competitive mechanism. The actions of ions on specific binding displayed similarities to the effects of ions on DL-[3H]2-amino-4-phosphonobutyric acid and Cl-/Ca2+-dependent L-[3H]glutamate ([3H]Glu) binding sites but were more consistent with the Glu-C binding site.

A comparison of 2-amino-4-phosphonobutyric acid (AP4) receptors and [3H]AP4 binding sites in the rat brain

The glutamate analogue 2-amino-4-phosphonobutyric acid (AP4) is a potent antagonist at several synapses where an excitatory amino acid appears to be the neurotransmitter. Previous studies identified a Cl-/Ca2+ dependent [3H]glutamate binding site in synaptic plasma membrane (SPM) preparations that was also labeled by [3H]AP4 and exhibited a pharmacology similar to the AP4 receptor. This report examines the pharmacological specificity in both biochemical and electrophysiological preparations in greater detail. Several compounds are identified which readily interact with the apparent binding site in membranes, but neither mimic nor inhibit the action of AP4 in electrophysiological studies. The rate of dissociation of [3H]AP4 from SPMs is shown to increase in the presence of added AP4 and increasing the osmolarity in the SPM binding assay decreases the level of observed [3H]AP4 binding. These findings indicate both a heterogeneous population of binding sites and the occurrence of transport. It is concluded that much of the AP4 binding observed in SPM preparations is to a site other than the AP4 receptor. The results provide a further pharmacological description of AP4 receptors which should facilitate the identification of the receptor in biochemical preparations.

Purine nucleotides inhibit the binding of DL-[3H] 2-amino-4-phosphonobutyrate (DL-[3H] APB) to L-glutamate-sensitive sites on rat brain membranes

The effects of purine nucleotides on the binding of DL-[3H] 2-amino-4-phosphonobutyrate (DL-[3H] APB) to rat brain membranes were investigated. Certain guanine nucleotides, especially cyclic GMP and GTP, were found to be potent inhibitors of binding. Kinetic studies revealed that both cyclic GMP and GTP acted to decrease receptor affinity without affecting significantly binding site density. These endogenous substances may therefore play an important role in the regulation of excitatory amino acid receptor function.

Specific binding of L-[3H]-glutamic acid to rat substantia nigra synaptic membranes

The specific binding of L-[3H]-glutamic acid (GLU) was investigated in synaptic membranes from rat substantia nigra. L-[3H]-GLU binding to the membrane preparations occurred in a reversible and saturable way. The specific binding was stimulated by the presence of CaCl2 and was reduced by freezing and thawing the membranes. Scatchard analysis of the saturation isotherms yielded a non-linear plot suggesting that the binding reaction does not occur through a simple bimolecular association. Assuming non-interacting binding sites, a high (KD1, 139 nM; Bmax1, 3.5 pmoles/mg protein) and a low (KD2, 667 nM; Bmax2, 15.1 pmoles/mg protein) affinity L-[3H]-GLU binding site were obtained. The kinetics of dissociation of bound L-[3H]-GLU was biphasic; the respective dissociation rate constant (k-1) being 0.20 min-1 and 0.013 min-1. A series of amino acid receptor agonists and antagonists were tested as inhibitors of L-[3H]-GLU specific binding. Quisqualic acid, L-GLU and D-alpha-aminoadipate (D-alpha-AA) were the most potent inhibitors. DL-2-amino-4-phosphonobutyrate (APB), N-Methyl-D-aspartate (NMDA) and D-GLU were moderate inhibitors, whereas diaminopimelic acid (DAPA) and glutamate diethyl ester (GDEE) exhibited the lowest relative potency. Kainic acid (KA), gamma-aminobutyric acid (GABA) and bicuculline were not able to modify at any concentration used the specific binding of L-[3H]-GLU. These data demonstrate the presence of specific GLU binding sites in synaptic structures at substantia nigra level and support the idea that excitatory amino acids may play a role in synaptic transmission in this brain region.

Cl-/Ca2+-dependent L-glutamate binding sites do not correspond to 2-amino-4-phosphonobutanoate-sensitive excitatory amino acid receptors

A series of phosphono and phosphino analogues of glutamate were used to compare the pharmacological properties of (a) Cl-/Ca2+-dependent, 2-amino-4-phosphonobutanoate (AP4)-sensitive L-[3H]-glutamate binding sites in rat brain synaptic plasma membranes (SPMs) and (b) AP4-sensitive excitatory synaptic responses by use of electrophysiological techniques. In the presence of Cl- and Ca2+, L-[3H]-glutamate bound to SPMs with Kd 804 nM and Bmax 53 pmol mg-1 protein. The AP4-sensitive (Ki 7.3 microM) population of binding sites represented 61% of L-glutamate specifically bound. omega-Substituted analogues of AP4 were potent inhibitors of L-[3H]-glutamate binding (Ki values 2.4-38 microM), whereas N-substituted compounds or propionic acid derivatives were inactive. Experiments with AP4 alone and in combination with other analogues demonstrated that the primary target of all substances was the AP4-sensitive population of L-glutamate binding sites. In the hippocampal slice in vitro, AP4 antagonized lateral perforant path-evoked field potentials with an IC50 of 2.7 microM. In contrast to their actions at AP4-sensitive L-glutamate binding sites, all other compounds (except for the omega-carboxymethylphosphino analogue, IC50 19 microM) were weak or inactive as antagonists of this synaptic response (IC50 values greater than 100 microM). Inactive compounds which exhibited activity in the binding assay did not reverse the synaptic depressant effects of AP4, indicating that they were neither agonists nor antagonists at AP4-sensitive synapses. 4 The lack of correspondence between (a) the Cl- /Ca2 -dependent, AP4-sensitive population of L- [3H]-glutamate binding sites and (b) AP4-sensitive synaptic responses indicates that these binding sites are not the receptors through which AP4 exerts its neuropharmacological effects. The possibility that Cl- /Ca2+-dependent 'binding sites' represent transport into resealed SPM vesicles is discussed. 5 Electrophysiological data demonstrate that AP4-sensitive synaptic receptors display a high degree of ligand selectivity. High antagonist potency is shown only by glutamate analogues with unmodified alpha-amino and alpha-carboxyl groups, and with a bifunctional (dianionic) omega-terminal.